指南与共识神经CT

斯堪的纳维亚神经创伤指南:65岁以上服用抗血小板药物患者颅内出血的发生频率

Scandinavian Neurotrauma Guidelines: Frequency of intracranial hemorrhage in patients over 65 years old and on anti-platelet medication.
指南 / 共识 · Eur J Radiol · 2024-10-06

该研究基于1年内325例65岁以上服用抗血小板药物、格拉斯哥昏迷评分14-15分的中风险头部外伤患者的头部CT报告,颅内出血患病率为5.2%。格拉斯哥昏迷评分14分者颅内出血风险高于15分者(RR 5.35,95%CI 2.14-13.47),氯吡格雷组颅内出血风险低于阿司匹林组(RR 0.33,95%CI 0.12-0.93)。作者认为需通过前瞻性研究确定该人群扫描的临床与医疗资源影响。

要点

  • 65岁以上服用抗血小板药物、GCS 14-15分头部外伤患者颅内出血患病率5.2%。
  • GCS 14分者颅内出血风险是GCS 15分者的5.35倍(RR 5.35,95%CI 2.14-13.47)。
  • 氯吡格雷组颅内出血风险低于阿司匹林组(RR 0.33,95%CI 0.12-0.93)。

核心结论

  • 该人群中头部CT颅内出血患病率为5.2%,GCS 14分较15分及氯吡格雷较阿司匹林与颅内出血风险相关。

研究设计与样本

  • 基于登记的回顾性研究,依据书面CT报告确定1年内325例头部CT的颅内出血患病率,并查阅病历与影像记录获取症状、客观发现与合并症数据。

诊断标准与关键数值

  • 2013年斯堪的纳维亚神经创伤委员会基于证据的指南推荐:年龄>65岁、服用抗血小板药物、GCS 14-15分的中风险头部外伤患者行头部CT。
  • 颅内出血患病率为5.2%(325例头部CT)。
  • GCS 14分较GCS 15分颅内出血风险比RR 5.35(95%CI 2.14-13.47)。
  • 氯吡格雷较阿司匹林颅内出血风险比RR 0.33(95%CI 0.12-0.93)。

临床应用与阅片要点

  • 对>65岁、服用抗血小板药物、GCS 14-15分的头部外伤患者,指南推荐行头部CT。
  • 作者指出颅内出血与GCS评分的关联提示全面临床检查对减少CT过度使用的重要性。
  • 作者认为该人群扫描对患者及医疗资源的影响应由未来前瞻性研究确定。

局限性

  • 原文结论指出该人群扫描对患者和医疗资源的影响需由未来前瞻性研究确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: In 2013, the Scandinavian Neurotrauma Committee, produced an evidence-based guideline for the use of Computed Tomography (CT) in patients presenting following recent (<24 h) head injury (HI). A head CT scan is recommended for medium-risk patients with a Glasgow Coma Scale (GCS) score of 14-15, who are > 65 years old and on anti-platelet medication. The aim of this study was to determine the prevalence of intracranial hemorrhage (ICH) on head CT scans in this population, and to test for associations between ICH and baseline characteristics, symptoms and objective clinical findings.

METHODS: This register-based retrospective study determined the prevalence of ICH on head CT scans performed over a 1-year period based on written CT-reports. Patient medical charts and imaging records were examined for data on symptomatology, objective findings and comorbidities.

RESULTS: The study population included 325 unique head CT scans with a 5.2% prevalence of ICH. Risk ratios (RR's) signified higher risk of ICH with a GCS score of 14 compared to a GCS score of 15 (RR 5.35, 95%CI 2.14-13.47). ICH risk was lower in patients on Clopidogrel medication compared to Acetylsalicylic Acid medication (RR 0.33, 95%CI 0.12-0.93).

CONCLUSIONS: The associations between ICH and the GCS score call attention to the importance of comprehensive clinical examination of HI patients to minimize CT overuse. The implications for patients and healthcare resources in scanning patients > 65 years on anti-platelet medication should be determined by future prospective studies.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Anetta Rathkjen S, Skjøth F, Arvad Serifi M, et al. Scandinavian Neurotrauma Guidelines: Frequency of intracranial hemorrhage in patients over 65 years old and on anti-platelet medication. Eur J Radiol. 2024. PMID: 39442349. doi:10.1016/j.ejrad.2024.111778

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。